From: Mechanism of salidroside against coronary artery disease by network pharmacology analysis
 | Module | Term | Description | -Log10(adjustP) |
---|---|---|---|---|
Targets of salidroside | MCODE_1 | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 7.4 |
MCODE_1 | GO:0050679 | positive regulation of epithelial cell proliferation | 7.2 | |
MCODE_1 | GO:0043410 | positive regulation of MAPK cascade | 6.2 | |
MCODE_2 | GO:0007218 | neuropeptide signaling pathway | 6.5 | |
MCODE_2 | GO:0006874 | cellular calcium ion homeostasis | 5.5 | |
MCODE_2 | GO:0055074 | calcium ion homeostasis | 5.4 | |
MCODE_3 | GO:0016052 | carbohydrate catabolic process | 5.8 | |
MCODE_3 | GO:0006091 | generation of precursor metabolites and energy | 5.6 | |
MCODE_3 | GO:0034308 | primary alcohol metabolic process | 5.3 | |
Targets of salidroside in the treatment of CAD | MCODE_1 | GO:0006091 | generation of precursor metabolites and energy | 5.4 |
MCODE_1 | GO:0005975 | carbohydrate metabolic process | 5.1 | |
MCODE_1 | GO:0016052 | carbohydrate catabolic process | 5.1 | |
MCODE_2 | GO:0070098 | chemokine-mediated signaling pathway | 4.7 | |
MCODE_2 | GO:1,990,869 | cellular response to chemokine | 4.6 | |
MCODE_2 | GO:1,990,868 | response to chemokine | 4.6 | |
MCODE_3 | GO:0050679 | positive regulation of epithelial cell proliferation | 5.9 | |
MCODE_3 | GO:0050678 | regulation of epithelial cell proliferation | 5.1 | |
MCODE_3 | GO:0050673 | epithelial cell proliferation | 4.9 |